T-Wave Microalternans in Hypertrophic Cardiomyopathy: The Complexity of an Inherited Cardiac Condition with Multiple Phenotypic Expressions

Overview

Journal Arq Bras Cardiol

Specialty Cardiology & Vascular Diseases

Date 2023 Nov 1

PMID 37909504

Authors

Jorge Elias Neto

Affiliations

Soon will be listed here.

References

Puntmann V, Yap Y, Mckenna W, Camm J . T-wave alternans and left ventricular wall thickness in predicting arrhythmic risk in patients with hypertrophic cardiomyopathy. Circ J. 2010; 74(6):1197-204. DOI: 10.1253/circj.cj-09-1003. View

Rosenbaum D, Jackson L, Smith J, Garan H, Ruskin J, Cohen R . Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med. 1994; 330(4):235-41. DOI: 10.1056/NEJM199401273300402. View

Salerno-Uriarte J, De Ferrari G, Klersy C, Pedretti R, Tritto M, Sallusti L . Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study. J Am Coll Cardiol. 2007; 50(19):1896-904. DOI: 10.1016/j.jacc.2007.09.004. View

Watanabe J, Koseki Y, Koyama J, Yamada A, Toda S, Shinozaki T . Microvolt T wave alternans in human cardiac hypertrophy: electrical instability and abnormal myocardial arrangement. J Cardiovasc Electrophysiol. 2001; 12(7):759-63. DOI: 10.1046/j.1540-8167.2001.00759.x. View

Rizzo S, Carturan E, De Gaspari M, Pilichou K, Thiene G, Basso C . Update on cardiomyopathies and sudden cardiac death. Forensic Sci Res. 2019; 4(3):202-210. PMC: 6713087. DOI: 10.1080/20961790.2019.1631957. View

Vandenberk B, Flore V, Rover C, Vos M, Dunnink A, Leftheriotis D . Repeating noninvasive risk stratification improves prediction of outcome in ICD patients. Ann Noninvasive Electrocardiol. 2020; 25(6):e12794. PMC: 7679829. DOI: 10.1111/anec.12794. View

Verrier R, Klingenheben T, Malik M, El-Sherif N, Exner D, Hohnloser S . Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive Electrocardiology. J Am Coll Cardiol. 2011; 58(13):1309-24. PMC: 4111570. DOI: 10.1016/j.jacc.2011.06.029. View

Chan P, Gold M, Nallamothu B . Do Beta-blockers impact microvolt T-wave alternans testing in patients at risk for ventricular arrhythmias? A meta-analysis. J Cardiovasc Electrophysiol. 2010; 21(9):1009-14. DOI: 10.1111/j.1540-8167.2010.01757.x. View

Antunes M, Samesima N, Filho H, Matsumoto A, Verrier R, Pastore C . Exercise-induced quantitative microvolt T-wave alternans in hypertrophic cardiomyopathy. J Electrocardiol. 2016; 50(2):184-190. DOI: 10.1016/j.jelectrocard.2016.10.010. View

10.

Wilde A, Semsarian C, Marquez M, Sepehri Shamloo A, Ackerman M, Ashley E . European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases. Europace. 2022; 24(8):1307-1367. PMC: 9435643. DOI: 10.1093/europace/euac030. View

11.

Maron B, Rowin E, Maron M . Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy. Circ Res. 2019; 125(4):370-378. DOI: 10.1161/CIRCRESAHA.119.315159. View

12.

Trzos E, Kasprzak J, Krzeminska-Pakula M, Rechcinski T, Wierzbowska-Drabik K, Uznanska B . The prevalence and the prognostic value of microvolt T-wave alternans in patients with hypertrophic cardiomyopathy. Ann Noninvasive Electrocardiol. 2011; 16(3):276-86. PMC: 6932658. DOI: 10.1111/j.1542-474X.2011.00443.x. View

13.

Oliveira Antunes M, Arteaga-Fernandez E, Samesima N, Filho H, Matsumoto A, Verrier R . Prognostic Evaluation of Microvolt T-Wave Alternans in Hypertrophic Cardiomyopathy: 9-year Clinical Follow-up. Arq Bras Cardiol. 2023; 120(8):e20220833. PMC: 10519242. DOI: 10.36660/abc.20220833. View

14.

Pagiatakis C, Di Mauro V . The Emerging Role of Epigenetics in Therapeutic Targeting of Cardiomyopathies. Int J Mol Sci. 2021; 22(16). PMC: 8395924. DOI: 10.3390/ijms22168721. View

15.

Pastore J, Girouard S, Laurita K, Akar F, Rosenbaum D . Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation. 1999; 99(10):1385-94. DOI: 10.1161/01.cir.99.10.1385. View

16.

Maron B, Rowin E, Maron M . Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator. Heart Rhythm. 2021; 18(6):1012-1023. DOI: 10.1016/j.hrthm.2021.01.019. View

17.

Ommen S, Mital S, Burke M, Day S, Deswal A, Elliott P . 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2020; 76(25):3022-3055. DOI: 10.1016/j.jacc.2020.08.044. View